Analysis of Ras-effector interaction competition in large intestine and colorectal cancer context

Cancer is the second leading cause of death globally, and colorectal cancer (CRC) is among the five most common cancers. The small GTPase KRAS is an oncogene that is mutated in ~30% of all CRCs. Pharmacological treatments of CRC are currently unsatisfactory, but much hope rests on network-centric ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibáňez Gaspar, Verónica, Catozzi, Simona, Ternet, Camille, Luthert, Philip J., Kiel, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939564/
https://www.ncbi.nlm.nih.gov/pubmed/32057289
http://dx.doi.org/10.1080/21541248.2020.1724596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939564/
https://www.ncbi.nlm.nih.gov/pubmed/32057289
http://dx.doi.org/10.1080/21541248.2020.1724596

Ejemplares similares